أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - ticagrelor, quantity: 90 mg - tablet, film coated - excipient ingredients: mannitol; hypromellose; titanium dioxide; magnesium stearate; hyprolose; iron oxide yellow; macrogol 400; calcium hydrogen phosphate dihydrate; purified talc - ticalor, in combination with aspirin, is indicated for the prevention of atherothrombotic events (cardiovascular death, myocardial infarction and stroke) in adult patients with acute coronary syndromes (unstable angina [ua], non st elevation myocardial infarction [nstemi] or st elevation myocardial infarction [stemi]) including patients managed medically, and those who are managed with percutaneous coronary intervention (pci) or coronary artery by-pass grafting (cabg).

سنغافورة - الإنجليزية - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - ticagrelor - tablet, film coated - ticagrelor 60 mg